| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9888162 | Clinica Chimica Acta | 2005 | 12 Pages |
Abstract
The exogenous heparin-derivative (LMWH) treatment attempted in this experimental model of hypercholesterolemic atherogenesis affords substantial protection against abnormal levels of aortic lipids and glycosaminoglycans, aortic oxidative stress and also stunts the lipoprotein peroxidative process, thereby proving its multi-faceted anti-atherogenic effects.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
P.R. Deepa, P. Varalakshmi,